Thank you for advocating for patient input into clinical trials. As a scientist and as a patient, this is so important!

~Jill

Featured Programs

Does the Transplant Treatment Approach Still Have Value for Myeloma Patients?

With the introduction of novel therapies, does the transplant treatment approach still have value for myeloma patients? Have transplants been replaced? Watch now to learn from myeloma experts what the latest data shows.

Published:

Myeloma Patient Cafe: How Are Myeloma Patients Managing Neuropathy?

How can multiple myeloma patients find relief from the painful tingling and numbness caused by neuropathy? Watch now to learn symptom management strategies from a patient panel.

Published:

How Is Remission Defined for Myeloma Patients With Refractory Status?

What determines a good response to therapy? What can patients in refractory status expect from treatment? Watch now to hear Dr. Jonathan Kaufman give an expert perspective on response, remission, minimal residual disease (MRD) and refractory status.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on November 16, 2018